Jet.AI announced the final post-closing purchase price for its merger with flyExclusive, resulting in flyExclusive issuing an additional 1,544,575 Class A common shares to previous recipients. This issuance completes the total consideration of 7,221,468 shares, marking a key step as Jet.AI shifts focus to high-performance GPU infrastructure and AI cloud services. The company plans to pursue further strategic opportunities to enhance shareholder value under its new business direction. The additional shares are expected to be distributed around October 30, 2026, with no action required from recipients.
Jet.AI's merger with flyExclusive involves the issuance of 1,544,575 additional shares, completing a total consideration of 7,221,468 shares. For readers following the Technology sector, here is Pluang's market snapshot as of Oct 29, 2026 19:13 WIB: out of 150 priced US tech stocks, 21 rose and 127 fell. Notable movers include NBIS at USD 169.30 with a 1-day change of -7.15% and a typical hold time of 26 days, OKTA at USD 206.95 down 7.06% with 100% buy order activity, and CRWD at USD 247.95 down 7.02% with 74% sell order activity.
The inaugural SportsTech Breakthrough Awards recognized leading companies and technologies advancing sports technology globally. Winners span categories like athlete performance, wearables, AI analytics, fan engagement, and smart stadium solutions, h...
The global Industrial Control System (ICS) Security Market is projected to grow from $17.91 billion in 2026 to $38.48 billion by 2031, at a CAGR of 16.5%. This growth is driven by rising cyberattacks targeting critical infrastructure and the increasi...
AdvantageLumber.com has introduced Sketch-A-Deck, a free online software that simplifies deck design for homeowners and contractors. The tool allows users to draw custom deck layouts, attach them to their homes, and generate build-ready plans with de...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
